# AiDing Diuresis wIth Tolvaptan (ADD-IT)

> **NCT02646540** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 14 (actual)

## Conditions studied

- Cardiomyopathy
- Congestive Heart Failure

## Interventions

- **DRUG:** Tolvaptan 30 mg + IV Diuretics
- **DRUG:** Metolazone 5 mg + IV Diuretics
- **DRUG:** 2.5 times the Diuretics Dose

## Key facts

- **NCT ID:** NCT02646540
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-12-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02646540

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02646540, "AiDing Diuresis wIth Tolvaptan (ADD-IT)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02646540. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*